Result 1 - 10 of total 24
The Psychological clinic
2017 Volume 9, Issue 4, Page(s) 118–121
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Psychological clinic
2017 Volume 8, Issue 7, Page(s) 201–207
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Psychological clinic
2017 Volume 9, Issue 2, Page(s) 51–55
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Psychological clinic
2017 Volume 7, Issue 5, Page(s) 127–134
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Psychological clinic
2017 Volume 8, Issue 4, Page(s) 93–98
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
Journal of the Royal Society, Interface
2021 Volume 18, Issue 178, Page(s) 20210256
Abstract: Most malaria infections in sub-Saharan Africa are acquired indoors, thus finding effective ways of preventing mosquito house entry should reduce transmission. Since most malaria mosquitoes fly less than 1 m from the ground, we tested whether raising ... ...
| Abstract | Most malaria infections in sub-Saharan Africa are acquired indoors, thus finding effective ways of preventing mosquito house entry should reduce transmission. Since most malaria mosquitoes fly less than 1 m from the ground, we tested whether raising buildings off the ground would prevent the entry of |
|---|---|
| MeSH term(s) | Africa ; Animals ; Anopheles ; Gambia ; Malaria/epidemiology ; Malaria/prevention & control ; Mosquito Control ; Mosquito Vectors |
| Language | English |
| Publishing date | 2021-05-26 |
| Publishing country | England |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 2156283-0 |
| ISSN | 1742-5662 ; 1742-5689 |
| ISSN (online) | 1742-5662 |
| ISSN | 1742-5689 |
| DOI | 10.1098/rsif.2021.0256 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2014 Volume 38, Issue 4, Page(s) 392–404
Abstract: Attorneys may hold expectations about jurors based on stereotypes about the relationships between demographic characteristics and attitudes. Attorneys test their hypotheses about prospective jurors during voir dire, but it is unclear whether their ... ...
| Abstract | Attorneys may hold expectations about jurors based on stereotypes about the relationships between demographic characteristics and attitudes. Attorneys test their hypotheses about prospective jurors during voir dire, but it is unclear whether their questioning strategies are likely to produce accurate information from jurors. In 2 studies, attorneys and law students formulated voir dire questions to test a particular hypothesis about the attitudes held by a prospective juror (venireperson) and provided their subsequent inferences about that individual given certain hypothetical responses to the questions. Bayes's theorem was used to compare attorneys' actual conclusions about the venireperson with the conclusions they would reach if correctly using the available information. Attorneys' conclusions were biased by the questions they asked, and in some cases, by the hypothesis that they were asked to test. Compared with normative models derived using Bayes' theorem, attorneys overrelied on venirepersons' responses when drawing conclusions about their attitudes. These findings suggest that even if traditional attorney-conducted voir dire elicited accurate information about prospective jurors' attitudes, attorneys may not use that information to draw normatively accurate conclusions about the attitudes that they hold. |
|---|---|
| MeSH term(s) | Bias ; Criminal Law ; Decision Making ; Female ; Humans ; Lawyers ; Male ; Stereotyping ; United States |
| Language | English |
| Publishing date | 2014-08 |
| Publishing country | United States |
| Document type | Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. |
| ZDB-ID | 2017882-7 |
| ISSN | 1573-661X ; 0147-7307 |
| ISSN (online) | 1573-661X |
| ISSN | 0147-7307 |
| DOI | 10.1037/lhb0000092 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of holistic nursing : official journal of the American Holistic Nurses' Association
2014 Volume 32, Issue 4, Page(s) 269–277
Abstract: Background: Although there is growing recognition of the importance of integrating spirituality within health care, there is little evidence to guide clinicians in how to best communicate with patients and family about their spiritual or existential ... ...
| Abstract | Background: Although there is growing recognition of the importance of integrating spirituality within health care, there is little evidence to guide clinicians in how to best communicate with patients and family about their spiritual or existential concerns. Methods: Using an audio-recorded home hospice nurse visit immediately following the death of a patient as a case-study, we identify spiritually-sensitive communication strategies. Results: The nurse incorporates spirituality in her support of the family by 1) creating space to allow for the expression of emotions and spiritual beliefs and 2) encouraging meaning-based coping, including emphasizing the caregivers' strengths and reframing negative experiences. Discussion: Hospice provides an excellent venue for modeling successful examples of spiritual communication. Health care professionals can learn these techniques to support patients and families in their own holistic practice. Implications for practice: All health care professionals benefit from proficiency in spiritual communication skills. Attention to spiritual concerns ultimately improves care. |
|---|---|
| MeSH term(s) | Caregivers/psychology ; Communication ; Delivery of Health Care/methods ; Female ; Home Care Services ; Hospices/methods ; Humans ; Male ; Mind-Body Therapies/methods ; Mind-Body Therapies/psychology ; Neoplasms/psychology ; Neoplasms/therapy ; Social Support ; Spirituality |
| Language | English |
| Publishing date | 2014-12 |
| Publishing country | United States |
| Document type | Journal Article ; Research Support, N.I.H., Extramural |
| ZDB-ID | 1033534-1 |
| ISSN | 1552-5724 ; 0898-0101 |
| ISSN (online) | 1552-5724 |
| ISSN | 0898-0101 |
| DOI | 10.1177/0898010114531856 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 2912: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Current medical research and opinion
2006 Volume 22, Issue 8, Page(s) 1493–1501
Abstract: Background: The transdermal fentanyl delivery system (fentanyl TTS; Duragesic) is currently widely available in patch strengths of 25, 50, 75, and 100 microg/h. However, a lower dose of 12 microg/h would allow optimal titration and fine tuning of the ... ...
| Abstract | Background: The transdermal fentanyl delivery system (fentanyl TTS; Duragesic) is currently widely available in patch strengths of 25, 50, 75, and 100 microg/h. However, a lower dose of 12 microg/h would allow optimal titration and fine tuning of the analgesic effect, and may be beneficial in certain patient populations such as the elderly or opioid-naïve. A 12 microg/h fentanyl TTS patch has been developed, and the clinical efficacy and safety tested in this single-arm, non-randomized, open-label, multicenter, 28-day trial in opioid-exposed and -naïve patients with moderate to severe pain for at least 6 months. Patients: Patients were treated with fentanyl TTS for 28 days in an intent-to-treat manner starting at 12 microg/h (one patch), titrated upwards in increments of 12 mug/h to a maximum dose of 36 microg/h (three patches). Results: A total of 227 patients were enrolled. The majority of patients with a "global assessment of therapy" of fair/poor at baseline (63.4%) improved to good/very good, while 28.9% of patients with an assessment of good/very good at baseline worsened to fair/poor at endpoint. The average pain intensity levels for the efficacy evaluable population steadily decreased over the course of the trial. The adverse event (AE) profile of fentanyl TTS in this trial was generally similar to that identified in previous fentanyl TTS trials, and no unexpected safety issues or AEs were noted. Furthermore, the drop-out rate in this trial was lower than has been noted in previous trials. Conclusion: This trial demonstrated that the lower 12 microg/h dose of fentanyl TTS provided a therapeutic benefit in non-malignant chronic pain, with a similar AE rate but a lower drop-out rate than that seen in trials at higher doses. This lower dose may, therefore, be of particular benefit to elderly or opioid-naïve patients. |
|---|---|
| MeSH term(s) | Administration, Cutaneous ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Analgesics, Opioid/administration & dosage ; Analgesics, Opioid/therapeutic use ; Chronic Disease/drug therapy ; Dose-Response Relationship, Drug ; Female ; Fentanyl/administration & dosage ; Fentanyl/adverse effects ; Fentanyl/therapeutic use ; Humans ; Male ; Middle Aged ; Pain/drug therapy ; Pain Measurement ; Palliative Care/methods ; Salvage Therapy ; Treatment Outcome |
| Chemical Substances | Analgesics, Opioid ; Fentanyl (UF599785JZ) |
| Language | English |
| Publishing date | 2006-08 |
| Publishing country | England |
| Document type | Clinical Trial, Phase III ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 80296-7 |
| ISSN | 1473-4877 ; 0300-7995 |
| ISSN (online) | 1473-4877 |
| ISSN | 0300-7995 |
| DOI | 10.1185/030079906X115540 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 955: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
PLoS ONE, Vol 14, Iss 10, p e
A prospective cohort study.
2019 Volume 0223603
Abstract: BACKGROUND:Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. METHODS AND FINDINGS:Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at ... ...
| Abstract | BACKGROUND:Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. METHODS AND FINDINGS:Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conducted a prospective controlled observational cohort study in 602 pregnant women who had or had not taken adalimumab. Women in the adalimumab-exposed cohort had received at least one dose of the drug in the first trimester for the treatment of rheumatoid arthritis or Crohn's Disease (N = 257). Women in the disease comparison cohort had not used adalimumab in pregnancy (N = 120). Women in the healthy comparison cohort had no rheumatic or inflammatory bowel diseases (N = 225). Women and their infants were followed to one year postpartum with maternal interviews, medical records abstraction, and physical examinations. Study outcomes were major structural birth defects, minor defects, spontaneous abortion, preterm delivery, pre and post-natal growth deficiency, serious or opportunistic infections and malignancies. 42/602 (7.0%) of pregnancies were lost-to-follow-up. 22/221 (10.0%) in the adalimumab-exposed cohort had a live born infant with a major birth defect compared to 8/106 (7.5%) in the diseased unexposed cohort (adjusted odds ratio 1.10, 95% confidence interval [CI] 0.45 to 2.73). Women in the adalimumab-exposed cohort were more likely to deliver preterm compared to the healthy cohort (adjusted hazard ratio [aHR] 2.59, 95% CI 1.22 to 5.50), but not compared to the diseased unexposed cohort (aHR 0.82, 95% CI 0.66 to 7.20). No significant increased risks were noted with adalimumab exposure for any other study outcomes. CONCLUSIONS:Adalimumab exposure in pregnancy compared to diseased unexposed pregnancies was not associated with an increased risk for any of the adverse outcomes examined. Women with rheumatoid arthritis or Crohn's Disease were at increased risk of preterm delivery, irrespective of adalimumab exposure. |
|---|---|
| Keywords | Medicine ; R ; Science ; Q |
| Subject code | 610 |
| Language | English |
| Publishing date | 2019-01-01T00:00:00Z |
| Publisher | Public Library of Science (PLoS) |
| Document type | Article ; Online |
| Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.